Medical genetic research on molecular basis of epigenetic regulation and human diseases
表观遗传调控分子基础与人类疾病的医学遗传学研究
基本信息
- 批准号:16209011
- 负责人:
- 金额:$ 31.62万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (A)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The project focused on the investigations of epigenetic gene regulation and related genetic phenomena including human diseases, and discovered a lot of new findings on DNA methyltransferases (DNMT), methylated DNA binding proteins (MBD proteins), chromatin insulator, genomic imprinting, and differentiation of mouse germ cells and embryonic stem cells (ES cells). Dr. Sasaki's group developed germ cell-specific knockout mice for DNMT3A and DNMT3B, and reported that these mice were sterile, and that DNMT3A-mediated DNA methylation during gametogenesis is required for establishing genomic imprinting. This result had a great impact on the imprinting mechanisms. In addition, studies of mutant mice deficient for DNMT3A or its associated factor named DNMT3L showed that aberrations of meiosis and transcriptional repression of transposons occurred in their testis, and that embryos derived from eggs of these mutant mice had abnormal placenta, resulting in the miscarriage. Further, Sasaki's group … More studied the distribution of CpG dinucleotides in male or female germ cell-specific methylated regions, and showed that DNMT3L or related factors can be implicated in development of ICF syndrome.MBD1 functions as a DNA methylation-mediated transcriptional repressor. Nakao's group reported that MBD1 recruits histone methyltransferase SETDB1 and its activating factor MCAF1 (MBD1-containing chromatin associated factor), resulting ir transcriptional repression and heterochromatin formation that is marked with trimethylation of 9th lysine of histone H3. In this case, SUMOylation of MBD1 is important for forming the MBD1-MCAF1-SETDB1 repressive complexes. It was also found that MBD1 and polycomb group proteins have overlapping roles in transcriptional repression and heterochromatin formation. In addition, MBD domain of MeCP2, another type of MBD proteins, is frequently mutated in Rett syndrome, and most MBD mutants lost the ability to bind methylated DNAs. Nakao group found that some MBD mutants retained the methylated DNA binding, suggesting the presence of unidentified mechanisms to develop this disease. Further, in the boundary elements of human genome, insulator binding protein CTCF was found to cooperate with chromatin remodeling factor CHD8, resulting in the enhancer blocking effect on H191IGF2 imprinted region. This is a first evidence for insulator linked to epigenetic remodeling. In neural differentiation of mouse ES cells, PML bodies and chromocenters were found to be remarkably reorganized, and Oct3/4 gene locus was differentially marked with histone acetylation and methylation, and DNA methylation at each stage of ES cells, neural precursor cells and terminally differentiated neurons. Less
该项目侧重于表观遗传基因调控和相关遗传现象的研究,包括人类疾病,并在小鼠生殖细胞和胚胎干细胞(ES细胞)的DNA甲基转移酶(DNMT)、甲基化DNA结合蛋白(MBD蛋白)、染色质绝缘体、基因组印迹和分化方面发现了许多新发现。佐佐木博士的团队开发了针对DNMT3A和DNMT3B的生殖细胞特异性基因敲除小鼠,并报告称,这些小鼠是不育的,配子发生期间DNMT3A介导的DNA甲基化是建立基因组印记所必需的。这一结果对印迹机理产生了很大的影响。此外,对缺乏DNMT3A或其相关因子DNMT3L的突变小鼠的研究表明,这些突变小鼠的睾丸发生了减数分裂和转座子转录抑制的异常,这些突变小鼠来自鸡蛋的胚胎有异常的胎盘,导致流产。此外,佐佐木的组合…进一步研究了CpG二核苷酸在男性或女性生殖细胞特异性甲基化区域的分布,发现DNMT3L或相关因素可能参与ICF综合征的发生。MBD1作为DNA甲基化介导的转录抑制因子发挥作用。Nakao的研究小组报道,MBD1招募了组蛋白甲基转移酶SETDB1及其激活因子MCAF1(含MBD1的染色质相关因子),导致IR转录抑制和异染色质形成,以组蛋白H3的第9个赖氨酸三甲基化为标志。在这种情况下,MBD1的SUMO化对于形成MBD1-MCAF1-SETDB1抑制复合体是重要的。研究还发现,MBD1和多梳蛋白在转录抑制和异染色质形成中的作用是重叠的。此外,另一种类型的MBD蛋白MeCP2的MBD结构域在Rett综合征中经常发生突变,大多数MBD突变失去了与甲基化DNA结合的能力。Nakao研究小组发现,一些MBD突变体保留了甲基化的DNA结合,表明存在尚未确定的发病机制。此外,在人类基因组的边界元件中,发现绝缘子结合蛋白CTCF与染色质重塑因子CHD8协同作用,导致增强子对H191IGF2印迹区域的封闭作用。这是绝缘体与表观遗传重塑有关的第一个证据。在小鼠ES细胞的神经分化过程中,PML小体和染色质中心明显重组,Oct3/4基因的组蛋白乙酰化和甲基化以及DNA甲基化在ES细胞、神经前体细胞和终末分化神经元的各个阶段进行了差异标记。较少
项目成果
期刊论文数量(101)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Activation of Sp1-mediated transcription by Rta of Epstein-Barr virus via an interaction with MCAF1.
- DOI:10.1093/nar/gki956
- 发表时间:2005
- 期刊:
- 影响因子:14.9
- 作者:Chang LK;Chung JY;Hong YR;Ichimura T;Nakao M;Liu ST
- 通讯作者:Liu ST
ゲノムワイドに展開するエピジェネティクス医科学
表观遗传学医学扩展到全基因组范围
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:中尾光善;塩田邦郎;牛島俊和;佐々木裕之(編集)
- 通讯作者:佐々木裕之(編集)
ICF syndrome in a girl with DNA hypomethylation but without detectable DNMT3B mutation
- DOI:10.1002/ajmg.a.30135
- 发表时间:2004-09-01
- 期刊:
- 影响因子:2
- 作者:Kubota, T;Furuumi, H;Kajii, T
- 通讯作者:Kajii, T
Stochastic imprinting in the progeny of Dnmt3L-/- females
- DOI:10.1093/hmg/ddi475
- 发表时间:2006-02-15
- 期刊:
- 影响因子:3.5
- 作者:Arnaud, P;Hata, K;Kelsey, G
- 通讯作者:Kelsey, G
Generation of SUMO-1 modified proteins in E-coli:: towards understanding the biochemistry/structural biology of the SUMO-1 pathway
- DOI:10.1016/s0014-5793(04)00321-7
- 发表时间:2004-04-23
- 期刊:
- 影响因子:3.5
- 作者:Uchimura, Y;Nakao, M;Saitoh, H
- 通讯作者:Saitoh, H
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAKAO Mitsuyoshi其他文献
NAKAO Mitsuyoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAKAO Mitsuyoshi', 18)}}的其他基金
Application of estrogen induced apoptosis in endocrine therapy-resistant breast cancer using Eleanor RNAs as an indicator
以Eleanor RNAs为指标的雌激素诱导细胞凋亡在内分泌治疗耐药乳腺癌中的应用
- 批准号:
18K19479 - 财政年份:2018
- 资助金额:
$ 31.62万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Anti-aging effect of lysine demethylase inhibition and its biomedical application
赖氨酸去甲基酶抑制的抗衰老作用及其生物医学应用
- 批准号:
24659152 - 财政年份:2012
- 资助金额:
$ 31.62万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Cellular energy control by lysine demethylation and its therapeutic potentials
赖氨酸去甲基化的细胞能量控制及其治疗潜力
- 批准号:
23659173 - 财政年份:2011
- 资助金额:
$ 31.62万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Multifunction of chromatin insulator and epigenetic regulation
染色质绝缘体的多功能和表观遗传调控
- 批准号:
22390055 - 财政年份:2010
- 资助金额:
$ 31.62万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
SUMO modification and nuclear remodeling in cell development
细胞发育中的 SUMO 修饰和核重塑
- 批准号:
19390078 - 财政年份:2007
- 资助金额:
$ 31.62万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Cancer development induced by deregulation of nuclear factors
核因子失调诱导癌症发展
- 批准号:
17013071 - 财政年份:2005
- 资助金额:
$ 31.62万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Development of a new strategy to control gene expression by chromatin conversion
开发通过染色质转换控制基因表达的新策略
- 批准号:
13557015 - 财政年份:2001
- 资助金额:
$ 31.62万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Mechanism of tumorigenesis by abnormal modification and regulation of intracellular molecules
细胞内分子异常修饰和调控的肿瘤发生机制
- 批准号:
13214086 - 财政年份:2000
- 资助金额:
$ 31.62万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Structure and function of a imprinting center in the region of human SNRPN gene
人类SNRPN基因印记中心的结构和功能
- 批准号:
09672312 - 财政年份:1997
- 资助金额:
$ 31.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
Got2基因对浆细胞样树突状细胞功能的调控及其在系统性红斑狼疮疾病中的作用研究
- 批准号:82371801
- 批准年份:2023
- 资助金额:47.00 万元
- 项目类别:面上项目
Pik3r2基因突变在家族内侧颞叶癫痫中的作用及发病机制研究
- 批准号:82371454
- 批准年份:2023
- 资助金额:47.00 万元
- 项目类别:面上项目
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
- 批准号:82371141
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
发展基因编码的荧光探针揭示趋化因子CXCL10的时空动态及其调控机制
- 批准号:32371150
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
22q11.2染色体微重复影响TOP3B表达并导致腭裂发生的机制研究
- 批准号:82370906
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
lncGEI诱导湖羊卵巢颗粒细胞E2合成的分子机制
- 批准号:32372856
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
RET基因634位点不同氨基酸改变对甲状腺C细胞的影响与机制研究
- 批准号:82370790
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
KMT2A基因突变通过DNMT3靶向调控GBP2导致神经发育障碍的机制研究
- 批准号:82371867
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
综合医疗机构引入Gene-Xpert MTB/RIF技术早期发现传染性肺结核和耐药肺结核的研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:0.0 万元
- 项目类别:省市级项目
Brahma related gene 1/Lamin B1通路在糖尿病肾脏疾病肾小管上皮细胞衰老中的作用
- 批准号:
- 批准年份:2021
- 资助金额:10.0 万元
- 项目类别:省市级项目
相似海外基金
Molecular and Cellular Regulation of Uterine Morphogenesis
子宫形态发生的分子和细胞调节
- 批准号:
10750127 - 财政年份:2024
- 资助金额:
$ 31.62万 - 项目类别:
Genetics of Extreme Phenotypes of OSA and Associated Upper Airway Anatomy
OSA 极端表型的遗传学及相关上呼吸道解剖学
- 批准号:
10555809 - 财政年份:2023
- 资助金额:
$ 31.62万 - 项目类别:
Cell cycle timing and molecular mechanisms of structural variant formation following incomplete replication
不完全复制后结构变异形成的细胞周期时间和分子机制
- 批准号:
10656861 - 财政年份:2023
- 资助金额:
$ 31.62万 - 项目类别:
Etiology and pathogenesis of lethal lung developmental disorders in neonates
新生儿致命性肺发育障碍的病因和发病机制
- 批准号:
10660107 - 财政年份:2023
- 资助金额:
$ 31.62万 - 项目类别:
Molecular Mechanisms of TRIB1 Regulation of Hepatic Metabolism
TRIB1调节肝脏代谢的分子机制
- 批准号:
10660520 - 财政年份:2023
- 资助金额:
$ 31.62万 - 项目类别:
Novel Computational Methods for Microbiome Data Analysis in Longitudinal Study
纵向研究中微生物组数据分析的新计算方法
- 批准号:
10660234 - 财政年份:2023
- 资助金额:
$ 31.62万 - 项目类别:
3D Methodology for Interpreting Disease-Associated Genomic Variation in RAG2
解释 RAG2 中疾病相关基因组变异的 3D 方法
- 批准号:
10724152 - 财政年份:2023
- 资助金额:
$ 31.62万 - 项目类别:
Modulation of Lifespan and Healthspan by Meiosis Genes
减数分裂基因对寿命和健康寿命的调节
- 批准号:
10724491 - 财政年份:2023
- 资助金额:
$ 31.62万 - 项目类别:
Genome Editing Therapy for Usher Syndrome Type 3
针对 3 型亚瑟综合症的基因组编辑疗法
- 批准号:
10759804 - 财政年份:2023
- 资助金额:
$ 31.62万 - 项目类别:














{{item.name}}会员




